Moreover, heparanase deficiency eliminated the development of albuminuria and renal damage in mouse models of diabetic nephropathy and glomerulonephritis, while the neutralization of enzyme activity by specific inhibitors resulted in reduced proteinuria in animal models of diabetic and non-diabetic proteinuric kidney diseases [14,15,16]. Here, HPSE is linked to diabetic kidney disease.